Detalhe da pesquisa
1.
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Blood
; 2024 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754055
2.
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia.
J Cell Mol Med
; 27(20): 3053-3064, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37654003
3.
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Haematologica
; 107(5): 1153-1162, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289655
4.
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.
Am J Hematol
; 91(6): 575-80, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26955792
5.
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care).
Leuk Lymphoma
; : 1-8, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38847543
6.
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies.
Leuk Lymphoma
; 65(4): 460-471, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164812
7.
Monoclonal gammopathy of undetermined significance: a new proposal of workup.
Eur J Haematol
; 91(4): 356-60, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23859528
8.
Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone (B-MuD) for the treatment of relapsed multiple myeloma.
Am J Hematol
; 88(2): 102-6, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23224960
9.
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.
Front Oncol
; 13: 1120967, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969038
10.
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Hemasphere
; 7(4): e837, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034003
11.
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706).
EJHaem
; 2022 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36248617
12.
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report.
Tumori
; 107(6): NP105-NP107, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34167407
13.
Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice.
Leuk Lymphoma
; 60(12): 2968-2974, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31169049
14.
Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma.
Br J Haematol
; 162(4): 555-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23718846
15.
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.
Leuk Lymphoma
; 58(3): 552-559, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27442600
16.
Implemented myeloma management with whole-body low-dose CT scan: a real life experience.
Leuk Lymphoma
; 57(7): 1539-45, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26788613
17.
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
Bone Marrow Transplant
; 55(12): 2350-2353, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541690
18.
Psychological care of caregivers, nurses and physicians: a study of a new approach.
Cancer Med
; 3(1): 101-10, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24402889
19.
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.
Leuk Lymphoma
; 55(9): 2032-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24730540
20.
The advantages of switch to subcutaneous bortezomib in the real life.
Leuk Lymphoma
; 59(6): 1505-1507, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28980500